Nitrosamine Risk Assessment in Outsourced Drug Manufacturing: A Sponsor Checklist

OEB Classification for Potent Compounds: How Sponsors Should Evaluate CDMO Capabilities

Managing high-potency drug portfolios requires meticulous containment strategies across shared contract manufacturing facilities. This comprehensive regulatory guide details how global drug sponsors…

Controlled Release Tablet Scale Up: Common Formulation Problems CDMOs Must Solve

Scaling oral solid dose therapies from laboratory settings to commercial manufacturing trains introduces severe mechanical challenges. This comprehensive technical guide analyzes the…

High Potency API Manufacturing: Containment Requirements Sponsors Must Understand

Transitioning toxic compound synthesis blocks toward advanced automated containment lines requires a highly disciplined validation baseline. This detailed technical evaluation examines the…

Excipient Compatibility Studies Explained for Formulation Teams

Designing stable therapeutic platforms requires an unyielding chemical orchestration baseline to prevent late-stage degradation patterns. This comprehensive industry analysis outlines the analytical…

Spray Drying ASD Scale-Up Challenges for Poorly Soluble Drugs

Formulating poorly soluble molecules requires a disciplined engineering baseline to prevent early phase failure patterns. This detailed technical analysis outlines the core…

Spray Drying ASD Scale-Up Challenges for Poorly Soluble Drugs

Formulating poorly soluble molecules requires a disciplined engineering baseline to prevent early phase failure patterns. This detailed technical analysis outlines the core…

Oral Solid Dose Tech Transfer: Common Delays and How to Avoid Them

Managing an oral solid dose tech transfer requires careful alignment of material properties and industrial machinery profiles. This comprehensive guide highlights the…

Pharmaceutical Technology Transfer Checklist: From R&D to Commercial Scale

Scaling drug production requires a robust pharma tech transfer checklist to bridge the gap between research and commercial manufacturing. This guide outlines…

How Pharmaceutical Companies Choose CDMOs: A Sponsor Decision Framework

Navigating the biologics CDMO list for 2026 requires an in-depth analysis of manufacturing capacity and technological innovation. This guide compares world-class biological…

Pharmaceutical Manufacturing Process Step-by-Step for Sponsors and Startups

Navigating drug development requires a robust pharma manufacturing process guide. This 2500-word resource provides sponsors and startups with a detailed analysis of…

The Pharmaceutical Tech Transfer Checklist Every Sponsor Should Use

Moving a drug product from the laboratory to commercial production requires a meticulous pharmaceutical tech transfer checklist. This 2500-word guide explores analytical…

Small Molecule Drug Manufacturing: Process Steps Explained

Small molecule drugs remain the backbone of modern medicine. This expert guide breaks down the complex small molecule drug manufacturing process, covering…

Biologics CDMO Outsourcing Strategy

Developing a robust biologics outsourcing strategy is essential for biotech sponsors navigating the high-stakes large-molecule market. This technical guide explores strategic triggers,…

How Long Biologics Manufacturing Takes

The timeline for biologics manufacturing is complex and time-consuming, often spanning several months for a single batch. This comprehensive 3000-word guide breaks…

How to Choose a Biologics CDMO

Choosing the right biologics CDMO is a high-stakes decision that impacts clinical timelines and patient safety. This guide outlines a structured selection…

How to Choose the Right CDMO for Drug Development (Sponsor Checklist)

Selecting a partner is a high-stakes decision. This guide on how to choose a CDMO for drug development provides a comprehensive sponsor…

What Does a CDMO Do? A Clear Guide to Pharmaceutical Manufacturing Partnerships

Discover what a CDMO does in pharmaceutical manufacturing and how these strategic partnerships accelerate drug development. This comprehensive guide explores the end-to-end…

Tracking the Critical Moments That Define Clinical Success

The next 12–18 months are shaping up to be unusually active for late-stage drug development as multiple high-profile candidates approach the end…

The Future of Drug Formulation: Why Next-Generation Lipid Nanoparticles Are Reshaping Modern Therapeutics

Lipid nanoparticles are rapidly transforming drug delivery, pushing formulation science to the center of modern therapeutic innovation. This column explores why next-generation…

RealPharm’s Inside the CMC Black Box

his RealPharma episode explores how CMC has become the hidden bottleneck in drug development, with Reza Oliyai revealing why manufacturing readiness, analytics,…

FDA’s CRL Transparency Reveals CMC Failures as the Primary Driver of Rejections

Navigating CMC Risks, Readiness, and Real-World Manufacturing Challenges The FDA’s new policy to publicly release Complete Response Letters (CRLs) marks a profound…

Alkermes’ 9 KPIs That Drive Successful CDMO Management Podcast Review

This week’s Pharma Podcast Pick highlights Alkermes’ deep dive into CDMO governance and the nine KPIs that transformed their external manufacturing partnerships.…

Pharmaceutical Podcast Pick

Pharma Podcast Picks highlights the most valuable insights from leading industry podcasts, delivering fast, curated intelligence for CDMO, biotech, and pharma professionals.…

Logistics Is the Strategic Engine Powering CDMO Growth

Pharmaceutical CDMOs are turning logistics from a support function into a strategic advantage. With biologics and advanced therapies on the rise, cold-chain…

Placebo to Match Sterile DP Solutions – Part II

Part II of this series explains the sterile fill-finish, analytical testing, CDMO selection, and supply-chain planning required to produce matched parenteral placebos…

Commercial Valuation of Clinical Trial Material  

Valuation of drug substance clinical trial supply materials

Transdermal Patch CDMOs USA: Leading Manufacturing & Development

Discover the leading Transdermal Patch CDMOs in the USA. Learn about cutting-edge technologies, the manufacturing process, regulatory compliance, and key cold chain…

Hello CDMO World: Launching Our Insightful Pharma Manufacturing Dialogue

Explore our first in-depth CDMO industry blog post, addressing market trends, technological innovation, regulatory alignment, and collaboration strategies in pharmaceutical contract development.

Onyx Scientific Limited Launches Industry-Focused Blog to Drive CDMO Engagement

Onyx Scientific Limited has published its inaugural blog post, signaling a strategic move to leverage content marketing, regulatory expertise, and digital engagement…